🟢 Gain Therapeutics is trading 8% up in pre-market with no clear catalyst identified

Gain Therapeutics is trading at $1.24, up 7.98%, with no new company-specific announcement identified to explain the pre-market rise.

• Latest listed company releases are dated October 8 and October 1.
• The Nasdaq Composite is up 0.52%, offering broader positive-market context but not establishing the cause of the stock’s move.
• Shares closed the previous session at $1.15, down 8.73%; the supplied alert describes an after-hours rebound without a clear catalyst.